SAFETY, TOLBERABILITY AND PHARMACOKINETICS OF MULTIPLE DOSES OF THE TRPV1 ANTAGONIST SAF312 IN HEALTHY SUBJECTS

被引：0
|
作者：
Schramm, U. [1 ]
Vaidya, S. [2 ]
Tavares, G. [3 ]
Roberts, J. [4 ]
Francke, K. [5 ]
El Mouelhi, M. [6 ]
机构：
[1] Novartis Inst BioMed Res Inc, Basel, Switzerland
[2] Novartis Inst BioMed Res Inc, Cambridge, Switzerland
[3] Novartis, Basel, Switzerland
[4] Novartis, E Hanover, NJ USA
[5] Parexel, Harrow, Middx, England
[6] Novartis Inst BioMedical Res Inc, E Hanover, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S68 / S69
页数：2
相关论文
共 50 条
  • [41] Effects of Multiple Doses of Clarithromycin on the Pharmacokinetics of Laropiprant in Healthy Subjects
    Wang, Ying-Hong
    Schwartz, Jules I.
    Luo, Wen-Lin
    Jumes, Patricia
    Desai, Rajesh
    Wenning, Larissa A.
    Wagner, John A.
    Lai, Eseng
    CARDIOVASCULAR THERAPEUTICS, 2011, 29 (02) : 140 - 145
  • [42] Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects
    Muralidharan, G
    Micalizzi, M
    Speth, J
    Raible, D
    Troy, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) : 220 - 229
  • [43] EFFECT OF MULTIPLE DOSES OF ISAVUCONAZOLE ON THE PHARMACOKINETICS OF SIROLIMUS IN HEALTHY SUBJECTS
    Yamazaki, T.
    Zadeikis, N.
    Pearlman, H.
    Desai, A.
    Kowalski, D.
    Townsend, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S114 - S114
  • [44] Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial
    Sonoyama, Takuhiro
    Shimizu, Ryosuke
    Kubota, Ryuji
    Matsuo, Yumiko
    Okutsu, Daiki
    Yamanaka, Hideki
    Takasu, Keiko
    Ogawa, Koichi
    Motomiya, Tomoko
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2023, 43 (03) : 346 - 358
  • [45] Single- and multiple dose pharmacokinetics and multiple dose pharmacodynamics of oral ABT-116 (a TRPV1 antagonist) in dogs
    Niyom, S.
    Mama, K. R.
    Gustafson, D. L.
    Rezende, M. L.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 (04) : 336 - 343
  • [46] A safety, tolerability, and pharmacokinetics (PK) study of single and multiple doses of lecozotan sustained release (SR), a novel S-HT1A antagonist, in healthy young subjects
    Raja, S.
    Parks, V.
    Plotka, A.
    Patas, A.
    Paul, J.
    Chalon, S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1121 - 1121
  • [47] Effects of Age, Sex, and Race on the Safety and Pharmacokinetics of Single and Multiple Doses of Azilsartan Medoxomil in Healthy Subjects
    Robert E. Harrell
    Aziz Karim
    Wencan Zhang
    Caroline Dudkowski
    Clinical Pharmacokinetics, 2016, 55 : 595 - 604
  • [48] Pharmacokinetics, safety, and tolerability of single and multiple-doses of pinocembrin injection administered intravenously in healthy subjects
    Cao, Guoying
    Ying, Pengyue
    Yan, Bei
    Xue, Wei
    Li, Kexin
    Shi, Aixin
    Sun, Taohua
    Yan, Jiling
    Hu, Xin
    JOURNAL OF ETHNOPHARMACOLOGY, 2015, 168 : 31 - 36
  • [49] Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of ascending multiple doses of SRA-333 in healthy subjects
    Raje, SV
    Plotka, A
    Parks, V
    Patat, A
    Chassard, D
    NEUROBIOLOGY OF AGING, 2004, 25 : S215 - S215
  • [50] Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects
    Patat, Alain
    Parks, Virginia
    Raje, Sangeeta
    Plotka, Anna
    Chassard, Didier
    Le Coz, F.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (03) : 299 - 308
12345